Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7360 p132
30 July 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Echinacea has no clinically significant effects on common cold

Extracts from Echinacea angustifolia roots have no clinically significant effects on common cold infection or illness, according to data published this week (New England Journal of Medicine 2005;353:341).

Ronald Turner, University of Virginia School of Medicine, Charlottesville, and colleagues tested three preparations of echinacea on 399 volunteers. The three phytochemically distinct preparations were produced by extraction from E angustifolia roots with supercritical carbon dioxide, 60 per cent ethanol or 20 per cent ethanol. Volunteers received echinacea prophylaxis (starting seven days before viral challenge) or treatment (starting at the time of challenge) or placebo. Viral challenge was with rhinovirus type 39, after which volunteers were isolated in individual hotel rooms for the following five days.

The researchers found that the echinacea preparations, either alone or in combination, had no effect on infection rate, symptoms or the course of the illness. “Given the great variety of echinacea preparations, it will be difficult to provide conclusive evidence that echinacea has no role in the treatment of the common cold. Our study, however, adds to the accumulating evidence that suggests that the burden of proof should lie with those who advocate this treatment,” they conclude.

Back to Top


©The Pharmaceutical Journal